Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides | Chemical Reviews |
| 11 | 2023 |
Reduction of the Renal Radioactivity of 111In-DOTA-Labeled Antibody Fragments with a Linkage Cleaved by the Renal Brush Border Membrane Enzymes | Journal of Medicinal Chemistry |
| 4 | 2023 |
An Improved 211At-Labeled Agent for PSMA-Targeted α-Therapy | Journal of Nuclear Medicine |
| 33 | 2022 |
Advancing Chelation Strategies for Large Metal Ions for Nuclear Medicine Applications | Accounts of Chemical Research |
| 21 | 2022 |
Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology | Journal for ImmunoTherapy of Cancer |
| 23 | 2022 |